The dean of the Stanford School of Medicine received direct consulting payments from opioid makers

Calley Means: "The dean (of the Stanford School of Medicine) Philip Pizzo was a pain specialist, Pfizer was the one of the largest opioid makers and he received direct consulting payments from opioid makers. And that year that they received that Pfizer grant he was appointed to an NIH panel to make opioid guidance with the burgeoning crisis. He selected that panel, how can you have a more prestigious person than dean of Stanford med school, 9 out of the 19 people he selected were directly paid for with consulting payments from opioid companies. And that panel in 2011, 2012 recommended more relaxed opioid standards and said the idea of addictiveness was overblown and led to an increase of the curve in opioid deaths. We're talking a lot about opioid crisis right now...majority of opioid overdose deaths started with a legal prescription. So that's how it works..."